Literature DB >> 15548978

High serum leptin in patients with chronic graft-versus-host disease after hematopoietic stem cell transplantation.

Libose Tauchmanovà1, Giuseppe Matarese, Carlo Carella, Gennaro De Rosa, Bianca Serio, Patrizia Ricci, Gaetano Lombardi, Bruno Rotoli, Annamaria Colao, Carmine Selleri.   

Abstract

BACKGROUND: Increased serum leptin has been described after various organ transplants, with a mechanism that is still unclear.
METHODS: We measured serum leptin in 60 patients before and after allogeneic (allo) or autologous (auto) stem cell transplant (SCT) and in 60 healthy controls, matched for age and body mass index (BMI).
RESULTS: Serum leptin was higher in patients after SCT than before and in controls. Leptin production was higher after allo- than after auto-SCT; the presence of chronic graft-versus-host disease (cGVHD) was associated with the highest values. The physiological correlation with BMI was lost in the allogeneic setting, indicating a strong influence of factors other than the nutritional status on circulating leptin. No relationship was found between serum leptin levels and time from transplant, age, cortisol, C-reactive protein, and T-lymphocyte CD4-to-CD8 ratio. Among the cytokines secreted by type-1/type-2 T-helper lymphocytes, only serum interferon-gamma significantly correlated with serum leptin levels. Anti-leptin blocking antibodies partially inhibited T-cell activation in mixed lymphocyte reaction, suggesting a link between leptin and T-lymphocyte activation in the allo-SCT setting.
CONCLUSION: Taken together, these findings suggest that increased serum leptin concentrations may contribute to T-cell activation during development of cGVHD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548978     DOI: 10.1097/01.tp.0000140485.20848.b7

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  A comparison between metabolic syndrome post-hematopoietic stem cell transplantation and spontaneously occurring metabolic syndrome.

Authors:  L Airaghi; P Usardi; S Forti; A Orsatti; M Baldini; C Annaloro; G Lambertenghi Deliliers
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

2.  Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.

Authors:  Eric J Chow; Jill H Simmons; Christian L Roth; K Scott Baker; Paul A Hoffmeister; Jean E Sanders; Debra L Friedman
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-01       Impact factor: 5.742

3.  Leptin and Inflammation.

Authors:  Noriko Iikuni; Queenie Lai Kwan Lam; Liwei Lu; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Immunol Rev       Date:  2008-05-01

4.  Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes.

Authors:  Lucie M Turcotte; Tao Wang; Michael T Hemmer; Stephen R Spellman; Mukta Arora; Ashley Yingst; Daniel Couriel; Amin Alousi; Joseph Pidala; Jennifer M Knight; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2018-08-23       Impact factor: 5.742

5.  High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.

Authors:  N S Majhail; M E Flowers; K K Ness; M Jagasia; P A Carpenter; M Arora; S Arai; L Johnston; P J Martin; K S Baker; S J Lee; L J Burns
Journal:  Bone Marrow Transplant       Date:  2008-08-25       Impact factor: 5.483

6.  Accelerated bone mass senescence after hematopoietic stem cell transplantation.

Authors:  B Serio; L Pezzullo; R Fontana; S Annunziata; R Rosamilio; M Sessa; V Giudice; I Ferrara; M Rocco; G De Rosa; P Ricci; L Tauchmanovà; N Montuori; C Selleri
Journal:  Transl Med UniSa       Date:  2013-01-04

7.  Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation.

Authors:  Mark-Alexander Schwarzbich; Hao Dai; Lambros Kordelas; Dietrich W Beelen; Aleksandar Radujkovic; Carsten Müller-Tidow; Peter Dreger; Thomas Luft
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

Review 8.  Distinct Regulatory and Effector T Cell Metabolic Demands during Graft-Versus-Host Disease.

Authors:  Keli L Hippen; Ethan G Aguilar; Stephanie Y Rhee; Sara Bolivar-Wagers; Bruce R Blazar
Journal:  Trends Immunol       Date:  2019-11-30       Impact factor: 16.687

9.  Undernutrition and Hypoleptinemia Modulate Alloimmunity and CMV-specific Viral Immunity in Transplantation.

Authors:  Emeraghi David; Minghua Zhu; Braden C Bennett; Daniel Cheng; Paul Schroder; Amanda Nichols; William Parker; Allan D Kirk; Nancie MacIver; Eileen T Chambers
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 5.385

Review 10.  Monogenic Immune Diseases Provide Insights Into the Mechanisms and Treatment of Chronic Graft-Versus-Host Disease.

Authors:  Jacob Rozmus
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.